Business
Supply shortages continue to challenge pharmacies
Pharmacy staff are being forced to deal with medicines shortages, with 60-day dispensing not making life any easier, pharmacist warns Suggestions from Department of Health and Aged Care bureaucrats, that …
Charac investment to boost MedAdvisor platform
Strategic deal to enhance the capabilities of MedAdvisor Solutions’ Plus One platform, while generating significant savings Australian Securities Exchange (ASX) listed medication management platform provider, MedAdvisor, is set to invest …
AFT sees 24% hike in sales
Flagship Maxigesic products and Australian OTC business contribute the most to latest half yearly results Maxigesic manufacturer AFT Pharmaceuticals has reported higher bottom-line profit and revenue after continued robust demand …
EBOS petcare bid falls over
Lack of enthusiasm from investors pegged as major factor in distributor withdrawing from Greencross purchase The anticipated $3.75 billion deal which would have seen pharmaceutical distributor EBOS buy up the …
Chemist Warehouse celebrates continued international expansion
First New Zealand CWH supplier event celebrates six years in NZ Discount pharmacy giant Chemist Warehouse (CWH) has held its inaugural supplier event in New Zealand to celebrate six years …
Cost remains a barrier to medicines
Increasing numbers of patients are delaying getting medicines or skipping scripts completely due to cost, Australian Bureau of Statistics (ABS) data reveals Cost barriers to accessing healthcare remain firmly in …
EBOS going to the dogs to avoid CWH doghouse?
Largest pharmaceutical wholesaler tipped to buy vet business to fill earnings hole left by CWH departure Multi-pronged pharmaceutical wholesaler and pharmacy owner EBOS has gone into an ASX trading halt …
Sales sentiment starts to struggle
Pharmacy real estate market starting to feel the bite of 60 day dispensing, survey shows The latest iteration of the Attain Pharmacy Market Sentiment Survey has revealed the impact of …
Ozempic fattens Commonwealth coffers – slightly
Ozempic manufacturer, Novo Nordisk’s tax bill more than doubled in the 2021/22 financial year, data from the Australian Taxation Office (ATO) reveals Surging demand for Novo Nordisk’s diabetes medication, Ozempic …
Main streets need pharmacies
Australians want a pharmacy above all other stores on their ideal main street Community pharmacies are seen as a must-have store for any town’s main street, a survey reveals. The …
And then there were three
Another consumer division spinoff on the way, this time by Sanofi Pharmaceutical giant Sanofi has portrayed how it imagines spinning off its consumer division and turning the parent, in the …
Scope expansion a win for MedAdvisor
Medtech firm sees profit growth on the back of “new scope” services in community pharmacy New pharmacist-delivered health services are fueling growth for the Australian Securities Exchange (ASX) listed medication …